LATEST NEWS

Subsidiary Signs Letters of Intent with Two Laser Manufacturers

Zecotek Subsidiary Signs Letters of Intent to Acquire Product and Intellectual Property Assets of Two Laser Manufacturers Vancouver, BC – February 27, 2007 – Zecotek Medical Systems Inc. (TSX-V: ZMS; Frankfurt: W1I.F) today announced that Zecotek Laser Systems Singapore Pte Ltd., a wholly-owned subsidiary, has signed two separate letters of intent (LOI) with two Russian-based […]

Read More

Closes Non-Brokered Private Placement for $3.5 Million

Zecotek Closes Non-Brokered Private Placement for $3.5 million Vancouver, February 19, 2007 – Zecotek Medical Systems Inc. (TSX-V: ZMS; Frankfurt: W1I.F) today reported that it has closed its previously announced non-brokered private placement for gross proceeds of $3,500,000. Due to strong investor demand the original $2,000,000 private placement announced on January 25, 2007, was increased […]

Read More

Non-Brokered Private Placement Increased to $3 Million

Zecotek Increases Non-Brokered Private Placement to $3 Million Vancouver, January 30, 2007 – Zecotek Medical Systems Inc. (TSX-V: ZMS; Frankfurt: W1I.F) is pleased to announce an increase to its non-brokered private placement, announced on January 25, 2007, to $3,000,000, consisting of up to 2,608,695 shares (the “Shares”) at a price of $1.15 per share. Pursuant […]

Read More

Non-Brokered Private Placement Announced

Zecotek Announces Non-Brokered Private Placement Vancouver, January 25, 2007 – Zecotek Medical Systems Inc. (TSX-Venture – ZMS; Frankfurt- W1I.F) today announced that the Company has arranged for a non-brokered private placement of 1,739,130 shares (the “Shares”) at $1.15 per share for gross proceeds of $2,000,000. Pursuant to the financing, the Company will pay a finder’s […]

Read More

Board and Management Changes Announced

Zecotek Announces Board and Management Changes Vancouver, January 22, 2007 – Zecotek Medical Systems Inc. (TSX-Venture – ZMS; Frankfurt – W1I.F) announces that, with a view of bringing added independence to its Board of Directors and as recommended by its Corporate Governance Committee, it has instituted a number of changes to the composition of its […]

Read More

Stock Options Granted

Zecotek Grants Stock Options Vancouver, January 15, 2007 – Zecotek Medical Systems Inc. (TSX-Venture – ZMS; Frankfurt- W1I.F) announces the granting of 160,000 stock options to Directors and employees for their contributions to the Company. The exercise price is set at $0.80 and will expire on January 15, 2012. The stock options are subject to […]

Read More
array-2

We have your Array needs covered

With our world first, automated robotic technique, we are able to rapidly produce scintillation crystal arrays with unmatched uniformity and precision allowing for excellent detector matching.
Faster, cheaper and uniform arrays are part of our business and can now be part of your modules.

SEE WHAT OUR CLIENTS HAVE TO SAY

  • “Zecotek provides LFS crystals required for the CMS experiment as they had the necessary energy resolution and radiation hardness . In using the thin LFS crystal plates Dr. Cox and his team were able to reduce the technical and cost risks associated with measurements in such experiments.”

    Professor Brad Cox
    Leader of the University of Virginia, CERN’s Compact Muon Solenoid experiment., University of Virginia
  • “Zecotek provided Cherry labs with a selection of scintillation crystals from their patented LFS-3 range. After preliminary testing Cherry labs found the crystals to have the fast decay constant they required, enhancing results for their depth-encoded PET detector designs. This combined with the competitive pricing Zecotek is able to offer made for an ideal solution.”

    Dr. Simon Cherry
    Head of Cherry Labs - UC Davis, Cherry Labs - UC Davis
  • “We are very excited to be working on the development of the future of displays. Zecoteks’ 3D display technology is the most promising solution to bringing and visualizing content in the next dimension and together we are confident that we can offer the market a ground breaking, viable and holistic product suitable for a variety of applications.”

    Vladimir Konev
    Head of Strategic development at Engineering Center NRNU MEPhI, Engineering Center NRNU MEPhI
3Ddisplay2

Explore our world in 3D

No glasses or other special equipment required for viewing

True Parallax

Same high resolution in 2D and 3D modes

No more "sweet spot" with our wide viewing angle

Patented time sharing technology preserves resolution in 2D & 3D modes

Explore More